Navigation Links
Pharma CI Conference Amy Yueh Pays $52,000 to Apaporis LLC to Satisfy Judgment Against Her In Superior Court Of New Jersey Case
Date:1/26/2010

TEANECK, N.J., Jan. 26 /PRNewswire/ -- Amy Yueh, the organizer of the Pharma CI Conference, who was sued in 2008 for alleged misappropriation of her employer's assets, has made payment of $52,000 by court order following judgment entered against her in the Superior Court of New Jersey. Yueh's trial took place in Hackensack, NJ.

Ellen Koblitz, Presiding Judge of the Superior Court of New Jersey stated in her ruling that Yueh "clearly took advantage of her employer by misleading 2008 conference participants." The decision represents compensation for "lost opportunity to compete on a level playing field had Yueh left and set up her own conference without misleading the potential participants."

In reaching decision, Judge Koblitz heard 3 1/2 days of testimony by Amy Yueh under questioning by lawyers for the prosecution. The Judge also accepted the introduction of testimony provided in depositions by former SCIP (Society of Competitive Intelligence Professionals) Presidents Cliff Kalb and Martha Matteo.

Yueh's motion to introduce testimony by Steve Levy of Fletcher CSI and her sister, Kelly Yueh, was denied by Judge Koblitz.

As part of the pre-trial proceedings counsel at Pfizer, Johnson & Johnson, Merck, sanofi-aventis, Bristol-Myers Squibb, and Novartis were subpoenaed in request of files detailing Yueh's email communications with various employees within the companies. The drug firms were helpful and the information provided was also recovered from her computer by forensic experts.

Previous articles and press releases on the case may be found at:

http://news.findlaw.com/prnewswire/20080813/13aug20080904.html

http://www.genengnews.com/news/bnitem.aspx?name=41654272

http://www.prnewswire.com/news-releases/50000-judgment-entered-against-defendant-amy-yueh-pharma-ci-conference-organizer-in-superior-court-of-new-jersey-62134257.html

http://www.njbiz.com/article.asp?aID=79155

Amy Yueh revealed in court documents that the 2008 Pharma CI Conference had revenues of $417,145 and net profits of $285,156.

The legal action was initiated in the Superior Court of New Jersey against Amy Yueh and her companies Acralinx Agenda and Amintell LLC.

Further litigation is pending.

CONTACT:  Mark Alexay, +1-201-452-4023, malexay@pharmabiotechci.com

SOURCE Apaporis LLC


'/>"/>
SOURCE Apaporis LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Collagen Matrix, Inc., ("Collagen Matrix") the driving ... collagen and mineral based medical devices for tissue ... Messer has joined the company as Vice ... growing portfolio of oral surgery, neurosurgery, orthopaedic and ... the Collagen Matrix executive team as an accomplished ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
Breaking Medicine News(10 mins):